🇺🇸 FDA
Pipeline program

Pimavanserin

H-48699

Approved small_molecule terminated

Quick answer

Pimavanserin for Insomnia Chronic is a Approved program (small_molecule) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ACADIA PHARMACEUTICALS INC
Indication
Insomnia Chronic
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials